MC1992A1 - Derives de fluorocytidine - Google Patents

Derives de fluorocytidine

Info

Publication number: MC1992A1
Authority: MC; Monaco
Prior art keywords: deoxy; fluoro; fluorocytidine; cytidine; radical
Prior art date: 1987-11-17

Application number

MC882015A

Other languages

English (en)

French (fr)

Inventor

Fujiu Morio

Ishitsuka Hideo

Miwa Masanori

Umeda Isao

Yokose Kazuteru

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-11-17

Filing date

1988-11-14

Publication date

1989-11-30

1988-11-14 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

1989-11-30 Publication of MC1992A1 publication Critical patent/MC1992A1/fr

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/067—Pyrimidine radicals with ribosyl as the saccharide radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Biotechnology (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

MC882015A 1987-11-17 1988-11-14 Derives de fluorocytidine MC1992A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP87116926		1987-11-17

Publications (1)

Publication Number	Publication Date
MC1992A1 true MC1992A1 (fr)	1989-11-30

Family

ID=8197450

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MC882015A MC1992A1 (fr)	1987-11-17	1988-11-14	Derives de fluorocytidine

Country Status (34)

Country	Link
US (1)	US4966891A (no)
EP (1)	EP0316704B1 (no)
JP (1)	JPH0678350B2 (no)
KR (1)	KR970000241B1 (no)
CN (1)	CN1022688C (no)
AR (1)	AR247217A1 (no)
AT (1)	ATE124951T1 (no)
AU (1)	AU619220B2 (no)
CA (1)	CA1327358C (no)
CS (1)	CS274486B2 (no)
DE (2)	DE3854148D1 (no)
DK (1)	DK170893B1 (no)
DZ (1)	DZ1270A1 (no)
ES (1)	ES2074429T3 (no)
FI (1)	FI89804C (no)
GR (1)	GR3017686T3 (no)
HU (1)	HU199866B (no)
IE (1)	IE883430L (no)
IL (1)	IL88363A0 (no)
IS (1)	IS1895B (no)
LT (1)	LT2185B (no)
LU (1)	LU90769I2 (no)
LV (1)	LV5624A3 (no)
MC (1)	MC1992A1 (no)
MX (1)	MX173347B (no)
NL (1)	NL300045I2 (no)
NO (2)	NO171167C (no)
NZ (1)	NZ226923A (no)
PH (1)	PH25641A (no)
PT (1)	PT89009B (no)
SU (1)	SU1736342A3 (no)
UA (1)	UA19333A (no)
YU (1)	YU47122B (no)
ZA (1)	ZA888428B (no)

Families Citing this family (90)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6258360B1 (en) *	1989-05-04	2001-07-10	Igen International, Inc.	Prodrugs activated by targeted catalytic proteins
US5527782A (en) *	1990-03-13	1996-06-18	Acic (Canada) Inc.	5-halo-2,3'-O-cyclocytidines
AU671491B2 (en) *	1992-12-18	1996-08-29	F. Hoffmann-La Roche Ag	N-oxycarbonyl substituted 5'-deoxy-5-fluorcytidines
TW254946B (no) *	1992-12-18	1995-08-21	Hoffmann La Roche
US5476932A (en) *	1994-08-26	1995-12-19	Hoffmann-La Roche Inc.	Process for producing N4-acyl-5'-deoxy-5-fluorocytidine derivatives
IT1291983B1 (it) *	1997-05-23	1999-01-25	Pro Bio Sint Srl	Prodcedimento per la preparazione di un derivato della desossiuridina
NZ330360A (en) *	1997-06-02	1999-03-29	Hoffmann La Roche	5'-deoxy-cytidine derivatives, their manufacture and use as antitumoral agents
EP0882734B1 (en) *	1997-06-02	2009-08-26	F. Hoffmann-La Roche Ag	5'-Deoxy-cytidine derivatives
US6005098A (en) *	1998-02-06	1999-12-21	Hoffmann-La Roche Inc.	5'deoxycytidine derivatives
US20080113025A1 (en) *	1998-11-02	2008-05-15	Elan Pharma International Limited	Compositions comprising nanoparticulate naproxen and controlled release hydrocodone
US20010051348A1 (en) *	2000-01-28	2001-12-13	Lee Chee Wee	Novel ligands and methods for preparing same
SE0102764D0 (sv)	2001-08-17	2001-08-17	Astrazeneca Ab	Compounds
EP1490090A4 (en)	2002-02-22	2006-09-20	New River Pharmaceuticals Inc	SYSTEMS FOR DELIVERING ACTIVE AGENTS AND METHODS FOR PROTECTING AND DELIVERING ACTIVE AGENTS
US6774758B2 (en) *	2002-09-11	2004-08-10	Kalyan P. Gokhale	Low harmonic rectifier circuit
GB0226930D0 (en)	2002-11-19	2002-12-24	Astrazeneca Ab	Chemical compounds
CA2525973A1 (en) *	2003-05-20	2004-12-09	Aronex Pharmaceuticals, Inc.	Combination chemotherapy comprising capecitabine and a liposomal platinum complex
DE602004015331D1 (de) *	2003-12-22	2008-09-04	Hoffmann La Roche	Verfahren für fluorcytidinderivate
ES2322709T3 (es) *	2004-02-18	2009-06-25	Astrazeneca Ab	Derivados de benzamida y su uso como agentes activadores de la glucocinasa.
EP1718625A1 (en) *	2004-02-18	2006-11-08	AstraZeneca AB	Compounds
CN100383128C (zh) *	2004-02-23	2008-04-23	上海迪赛诺医药发展有限公司	N4－氧羰基胞嘧啶衍生物及制备方法与应用
TW200600086A (en)	2004-06-05	2006-01-01	Astrazeneca Ab	Chemical compound
KR101061850B1 (ko)	2004-09-08	2011-09-02	삼성전자주식회사	박막 트랜지스터 표시판 및 그 제조방법
GB0421294D0 (en) *	2004-09-24	2004-10-27	Angiogene Pharm Ltd	Bioreductively-activated prodrugs
GB0423043D0 (en) *	2004-10-16	2004-11-17	Astrazeneca Ab	Compounds
AU2005293343B2 (en)	2004-10-16	2009-03-19	Astrazeneca Ab	Process for making phenoxy benzamide compounds
BRPI0606839B8 (pt)	2005-02-03	2021-12-14	Massachusetts Gen Hospital	Uso de uma composição farmacêutica compreendendo um inibidor irreversível de receptor de fator de crescimento epidérmico (egfr)
NO322682B1 (no) *	2005-03-18	2006-11-27	Clavis Pharma Asa	Anvendelse av gemcitabinderivater for fremstilling av orale doseringsformer ved kreftbehandling, samt slike orale doseringsformer
WO2006103187A2 (en) *	2005-04-01	2006-10-05	F. Hoffmann-La Roche Ag	Method for administration of capecitabine
JP2008542247A (ja) *	2005-05-24	2008-11-27	アストラゼネカアクチボラグ	グルコキナーゼモジュレーターとしての２−フェニル置換イミダゾール［４，５ｂ］ピリジン／ピラジンおよびプリン誘導体
TW200714597A (en)	2005-05-27	2007-04-16	Astrazeneca Ab	Chemical compounds
EP2027113A1 (en) *	2005-07-09	2009-02-25	AstraZeneca AB	Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
EP1910350A1 (en) *	2005-07-09	2008-04-16	AstraZeneca AB	2 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes
EP2301935A1 (en)	2005-07-09	2011-03-30	AstraZeneca AB (Publ)	Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
CN100569790C (zh) *	2005-07-15	2009-12-16	上海奥锐特国际贸易有限公司	合成n4-酰基-5＇-脱氧-5-氟胞苷衍生物的方法
ES2384267T3 (es)	2005-07-21	2012-07-03	Nuvo Research Ag	Soluciones de clorito estabilizadas en combinación con fluoropirimidinas para el tratamiento del cáncer
US9202182B2 (en) *	2005-08-11	2015-12-01	International Business Machines Corporation	Method and system for analyzing business architecture
RU2451524C2 (ru)	2005-11-04	2012-05-27	Вайет	Противоопухолевые комбинации с ингибиторами mtor, герцептином и/или hki-272
TW200738621A (en)	2005-11-28	2007-10-16	Astrazeneca Ab	Chemical process
US20080085310A1 (en) *	2006-10-06	2008-04-10	Maria Oksana Bachynsky	Capecitabine rapidly disintegrating tablets
TW200825063A (en)	2006-10-23	2008-06-16	Astrazeneca Ab	Chemical compounds
SA07280576B1 (ar)	2006-10-26	2011-06-22	استرازينيكا ايه بي	مركبات بنزويل أمينو سيكليل غير متجانسة بأعتبارها عوامل منشطة للجلوكوكيناز
CN100425617C (zh) *	2006-10-31	2008-10-15	浙江海正药业股份有限公司	一种含氟嘧啶类化合物烷氧羰酰化的方法
BRPI0721143A2 (pt)	2006-12-21	2014-03-11	Astrazeneca Ab	Forma cristalina do composto processo para a formação da mesma, uso de um composto, método para tratar doenças mediadas por ativador de glicocinase
ITMI20070435A1 (it)	2007-03-05	2008-09-06	Innovate Biotechnology Srl	2',3'-di-o-acil-5-fluoronucleosidi
KR20100015568A (ko) *	2007-04-20	2010-02-12	닥터 레디스 레보러터리즈 리미티드	카페시타빈의 제조 방법
WO2008145403A1 (en) *	2007-06-01	2008-12-04	Synthon B.V.	Processes related to making capecitabine
WO2009042064A2 (en)	2007-09-21	2009-04-02	Nektar Therapeutics Al, Corporation	Oligomer-nucleoside phosphate conjugates
US8022216B2 (en)	2007-10-17	2011-09-20	Wyeth Llc	Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
WO2009088989A1 (en) *	2008-01-03	2009-07-16	Plus Chemicals, S.A.	Process for the preparation of capecitabine
SG191676A1 (en)	2008-06-17	2013-07-31	Wyeth Llc	Antineoplastic combinations containing hki-272 and vinorelbine
BRPI0917589A2 (pt)	2008-08-04	2015-11-17	Astrazeneca Ab	composto, composição farmacêutica, uso de um composto, método para tratar doenças, processo, combinação farmacêutica, e, reação de metiloxirano-2-carboxilato (ix) com um álcool roh
CN109464445A (zh) *	2008-08-04	2019-03-15	惠氏有限责任公司	4-苯胺基-3-氰基喹啉和卡培他滨的抗肿瘤组合
EP2370414A4 (en) *	2008-12-02	2012-11-14	Reddys Lab Ltd Dr	PREPARATION OF CAPECITABINE
WO2010063080A1 (en)	2008-12-05	2010-06-10	Commonwealth Scientific And Industrial Research Organisation	Amphiphile prodrugs
CN101787066B (zh) *	2009-01-23	2013-07-31	高峰	阿糖胞苷衍生物及其在抗癌抗肿瘤中的用途
GB0902434D0 (en)	2009-02-13	2009-04-01	Astrazeneca Ab	Chemical process
GB0902406D0 (en)	2009-02-13	2009-04-01	Astrazeneca Ab	Crystalline polymorphic form
SG174382A1 (en)	2009-04-06	2011-11-28	Wyeth Llc	Treatment regimen utilizing neratinib for breast cancer
AR076220A1 (es)	2009-04-09	2011-05-26	Astrazeneca Ab	Derivados de pirazol [4,5 - e] pirimidina
WO2010116176A1 (en) *	2009-04-09	2010-10-14	Astrazeneca Ab	Pyrazolo [4, 5-e] pyrimidine derivative and its use to treat diabetes and obesity
CN101875680B (zh) *	2009-04-28	2012-07-25	上海信旗医药科技有限公司	一种核苷类化合物及其制备方法和应用
JP2012533618A (ja) *	2009-07-23	2012-12-27	サイノファームタイワンリミテッド	フルオロシチジン誘導体の製造プロセス
JP5917418B2 (ja)	2010-03-12	2016-05-11	ジェンザイム・コーポレーションＧｅｎｚｙｍｅＣｏｒｐｏｒａｔｉｏｎ	乳がんを治療するための併用療法
JP2015513912A (ja)	2012-04-02	2015-05-18	モデルナセラピューティクスインコーポレイテッドＭｏｄｅｒｎａＴｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ．	タンパク質の産生のための修飾ポリヌクレオチド
CN104411338A (zh)	2012-04-02	2015-03-11	现代治疗公司	用于产生与人类疾病相关的生物制剂和蛋白质的修饰多核苷酸
US9328106B2 (en)	2012-09-26	2016-05-03	Genentech, Inc.	Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
CA2890359A1 (en) *	2012-11-07	2014-05-15	Zucai SUO	Substituted gemcitabine aryl amide analogs and treatment methods using same
WO2014152027A1 (en)	2013-03-15	2014-09-25	Moderna Therapeutics, Inc.	Manufacturing methods for production of rna transcripts
US10000521B2 (en)	2013-03-15	2018-06-19	Nucorion Pharmaceuticals, Inc.	Substituted gemcitabine bicyclic amide analogs and treatment methods using same
EP3041934A1 (en)	2013-09-03	2016-07-13	Moderna Therapeutics, Inc.	Chimeric polynucleotides
EP3041938A1 (en)	2013-09-03	2016-07-13	Moderna Therapeutics, Inc.	Circular polynucleotides
CN103450301B (zh) *	2013-09-09	2015-09-09	南通大学	法尼基硫代水杨酸-核苷缀合物、其制备方法及其医药用途
CN105980401A (zh)	2013-10-03	2016-09-28	现代治疗公司	编码低密度脂蛋白受体的多核苷酸
US10858349B2 (en) *	2016-06-28	2020-12-08	Cellix Bio Private Limited	Compositions and methods for the treatment of cancer
US11584733B2 (en)	2017-01-09	2023-02-21	Shuttle Pharmaceuticals, Inc.	Selective histone deacetylase inhibitors for the treatment of human disease
ES2914123T3 (es)	2017-01-09	2022-06-07	Shuttle Pharmaceuticals Inc	Inhibidores selectivos de la histona desacetilasa para el tratamiento de una enfermedad humana
EP3618837A4 (en)	2017-04-26	2020-11-04	Thomas I. Kalman	MULTI-DIRECTIONAL NUCLEOSIDE DERIVATIVES
US10435429B2 (en)	2017-10-03	2019-10-08	Nucorion Pharmaceuticals, Inc.	5-fluorouridine monophosphate cyclic triester compounds
CA3087565A1 (en)	2018-01-09	2019-07-18	Shuttle Pharmaceuticals, Inc.	Selective histone deacetylase inhibitors for the treatment of human disease
CA3088287A1 (en)	2018-01-10	2019-07-18	Nucorion Pharmaceuticals, Inc.	Phosphor(n)amidatacetal and phosph(on)atalcetal compounds
WO2019143860A1 (en) *	2018-01-19	2019-07-25	Nucorion Pharmaceuticals, Inc.	5-fluorouracil compounds
US11427550B2 (en)	2018-01-19	2022-08-30	Nucorion Pharmaceuticals, Inc.	5-fluorouracil compounds
MX2021000740A (es) *	2018-08-03	2021-03-26	Cellix Bio Private Ltd	Composiciones y metodos para el tratamiento del cancer.
CN109651467A (zh) *	2019-01-15	2019-04-19	齐鲁天和惠世制药有限公司	一种卡培他滨杂质及其制备方法
AU2020315394A1 (en)	2019-07-17	2022-02-17	Nucorion Pharmaceuticals, Inc.	Cyclic deoxyribonucleotide compounds
EP4143199B1 (en)	2020-04-21	2025-11-19	Ligand Pharmaceuticals, Inc.	Nucleotide prodrug compounds
CN116710079A (zh)	2020-07-24	2023-09-05	斯特兰德生物科技公司	包含经修饰的核苷酸的脂质纳米颗粒
AR124599A1 (es)	2021-01-08	2023-04-12	Strand Therapeutics Inc	Constructos de expresión y usos de estos
IL316186A (en)	2022-04-26	2024-12-01	Strand Therapeutics Inc	Lipid nanoparticles containing Venezuelan equine encephalitis (VEE) replicon and uses thereof
WO2025193628A2 (en)	2024-03-09	2025-09-18	Aadigen, Llc	Compositions for treating cancer with kras mutations and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3404144A (en) *	1965-12-23	1968-10-01	Research Corp	1-beta-d-arabinofuranosyl-5-fluorocytosine compounds
GB1379410A (en) *	1971-06-08	1975-01-02	Upjohn Co	1-beta-d-arabino-furanosyl-n4-alpha-aminoacylcytosines
JPS52153977A (en) *	1976-06-11	1977-12-21	Daikin Ind Ltd	Synthesis of 5-fluorouracil and its derivatives
US4071680A (en) *	1976-12-20	1978-01-31	Hoffmann-La Roche Inc.	5'-Deoxy-5-fluoropyrimidine nucleosides
CH633810A5 (en) *	1978-01-01	1982-12-31	Hoffmann La Roche	Novel nucleosides and process for their preparation
FR2528311B1 (fr) *	1982-06-14	1985-06-14	Synthelabo	Compositions pharmaceutiques a base de xylosides et lyxosides de bases puriques et pyrimidiques
JPS61112093A (ja) *	1984-11-05	1986-05-30	Wakunaga Seiyaku Kk	ヌクレオチド誘導体

1988
- 1988-11-02 CA CA000581964A patent/CA1327358C/en not_active Expired - Lifetime
- 1988-11-07 ES ES88118515T patent/ES2074429T3/es not_active Expired - Lifetime
- 1988-11-07 DE DE3854148T patent/DE3854148D1/de not_active Expired - Lifetime
- 1988-11-07 AT AT88118515T patent/ATE124951T1/de active
- 1988-11-07 EP EP88118515A patent/EP0316704B1/de not_active Expired - Lifetime
- 1988-11-07 DE DE2001199027 patent/DE10199027I2/de active Active
- 1988-11-08 US US07/268,437 patent/US4966891A/en not_active Expired - Lifetime
- 1988-11-10 YU YU209188A patent/YU47122B/sh unknown
- 1988-11-10 ZA ZA888428A patent/ZA888428B/xx unknown
- 1988-11-10 NZ NZ226923A patent/NZ226923A/xx unknown
- 1988-11-11 IL IL88363A patent/IL88363A0/xx not_active IP Right Cessation
- 1988-11-14 JP JP63285940A patent/JPH0678350B2/ja not_active Expired - Lifetime
- 1988-11-14 MC MC882015A patent/MC1992A1/fr unknown
- 1988-11-14 HU HU885799A patent/HU199866B/hu unknown
- 1988-11-15 KR KR1019880014983A patent/KR970000241B1/ko not_active Expired - Lifetime
- 1988-11-15 CS CS747588A patent/CS274486B2/cs not_active IP Right Cessation
- 1988-11-16 AR AR88312471A patent/AR247217A1/es active
- 1988-11-16 DK DK640388A patent/DK170893B1/da not_active IP Right Cessation
- 1988-11-16 AU AU25168/88A patent/AU619220B2/en not_active Expired
- 1988-11-16 PT PT89009A patent/PT89009B/pt not_active IP Right Cessation
- 1988-11-16 SU SU884356869A patent/SU1736342A3/ru active
- 1988-11-16 DZ DZ880179A patent/DZ1270A1/fr active
- 1988-11-16 IS IS3412A patent/IS1895B/is unknown
- 1988-11-16 NO NO885106A patent/NO171167C/no not_active IP Right Cessation
- 1988-11-16 UA UA4356869A patent/UA19333A/uk unknown
- 1988-11-16 PH PH37820A patent/PH25641A/en unknown
- 1988-11-16 CN CN88107886A patent/CN1022688C/zh not_active Expired - Lifetime
- 1988-11-16 IE IE883430A patent/IE883430L/xx not_active IP Right Cessation
- 1988-11-17 FI FI885329A patent/FI89804C/fi not_active IP Right Cessation
- 1988-11-17 MX MX013836A patent/MX173347B/es unknown
1993
- 1993-06-08 LV LV930507A patent/LV5624A3/xx unknown
- 1993-07-20 LT LTRP802A patent/LT2185B/xx not_active IP Right Cessation
1995
- 1995-10-10 GR GR950402791T patent/GR3017686T3/el unknown
2001
- 2001-05-02 LU LU90769C patent/LU90769I2/fr unknown
- 2001-05-17 NL NL300045C patent/NL300045I2/nl unknown
- 2001-07-17 NO NO2001013C patent/NO2001013I2/no unknown

Also Published As

Publication number	Publication date
DK170893B1 (da)	1996-03-04
NO2001013I2 (no)	2006-05-01
EP0316704A2 (de)	1989-05-24
NZ226923A (en)	1990-10-26
US4966891A (en)	1990-10-30
DZ1270A1 (fr)	2004-09-13
DE10199027I2 (de)	2002-01-31
AU619220B2 (en)	1992-01-23
DE10199027I1 (de)	2001-08-02
FI89804C (fi)	1993-11-25
AR247217A1 (es)	1994-11-30
ZA888428B (en)	1989-06-28
ATE124951T1 (de)	1995-07-15
HK1003114A1 (en)	1998-10-09
NO171167B (no)	1992-10-26
FI885329A0 (fi)	1988-11-17
CA1327358C (en)	1994-03-01
LT2185B (lt)	1993-10-15
NL300045I1 (nl)	2001-08-01
FI89804B (fi)	1993-08-13
AU2516888A (en)	1989-05-25
EP0316704B1 (de)	1995-07-12
HU199866B (en)	1990-03-28
CN1022688C (zh)	1993-11-10
LV5624A3 (lv)	1994-05-10
YU47122B (sh)	1994-12-28
GR3017686T3 (en)	1996-01-31
IL88363A0 (en)	1989-06-30
PT89009A (pt)	1988-12-01
CS274486B2 (en)	1991-04-11
YU209188A (en)	1990-08-31
CS747588A2 (en)	1990-09-12
NL300045I2 (nl)	2002-01-02
NO171167C (no)	1993-02-03
IE883430L (en)	1989-05-17
NO885106L (no)	1989-05-18
FI885329L (fi)	1989-05-18
DE3854148D1 (de)	1995-08-17
ES2074429T3 (es)	1995-09-16
JPH01153696A (ja)	1989-06-15
JPH0678350B2 (ja)	1994-10-05
SU1736342A3 (ru)	1992-05-23
MX13836A (es)	1993-10-01
CN1033183A (zh)	1989-05-31
KR970000241B1 (ko)	1997-01-08
UA19333A (uk)	1997-12-25
PT89009B (pt)	1993-02-26
PH25641A (en)	1991-08-21
KR890008162A (ko)	1989-07-10
LU90769I2 (fr)	2001-07-02
DK640388A (da)	1989-05-18
EP0316704A3 (en)	1990-11-22
NO885106D0 (no)	1988-11-16
HUT48267A (en)	1989-05-29
IS3412A7 (is)	1989-05-18
MX173347B (es)	1994-01-03
DK640388D0 (da)	1988-11-16
IS1895B (is)	2003-10-20

Publication	Publication Date	Title
MC1992A1 (fr)	1989-11-30	Derives de fluorocytidine
FI93217C (fi)	1995-03-10	Menetelmä terapeuttisesti aktiivisten nukleosidijohdannaisten estereiden ja amidien valmistamiseksi
JP3530218B2 (ja)	2004-05-24	▲ｎ４▼−アシル−５’−デオキシ−５−フルオロシチジン誘導体の新規製造法
DE69302360T2 (de)	1996-10-31	N-Oxycarbonyl substitutierte 5'-Deoxy-5-Fluorocytidin
US5506347A (en)	1996-04-09	Lyxofuranosyl analogues of adenosine
US5464826A (en)	1995-11-07	Method of treating tumors in mammals with 2',2'-difluoronucleosides
EP0717748B1 (fr)	1997-12-17	Composes 2' ou 3'-deoxy- et 2', 3'-dideoxy-beta-l-pentofuranonucleosides, procede de preparation et application therapeutique, notamment anti-virale
JPH069602A (ja)	1994-01-18	ジフルオロ抗ウイルス剤の中間体
US4071680A (en)	1978-01-31	5'-Deoxy-5-fluoropyrimidine nucleosides
HUT70765A (en)	1995-10-30	Immunregulator rapamycin derivatives of activity, pharmaceutical compositions containing them and process for preparing them
HU199500B (en)	1990-02-28	Process for producing pyrimidine derivatives
EP0129984A1 (en)	1985-01-02	Novel 2'-deoxy-5-substituted uridine derivatives, processes for preparing the same and antitumor agent containing the same
US6613896B1 (en)	2003-09-02	Method of producing tiazofurin and other C-nucleosides
FR2499577A1 (fr)	1982-08-13	Nouvelles 1-(2-chloroethyl)-1-nitrosourees-3-substituees par un reste de sucre, utiles notamment comme agents antitumoraux et leur procede de preparation
EP0572669A1 (en)	1993-12-08	1-B(beta)-D-Arabinofuranosyl-(E)-5-(2-halogenovinyl)-uracil-derivative
WO1992006993A1 (fr)	1992-04-30	Nouveaux composes ribonucleosides, leur procede de preparation et les medicaments comprenant ces composes
EP0303269A2 (en)	1989-02-15	2'-Deoxy-5-fluorouridine derivatives, process for preparing the same and the use thereof
FR2900152A1 (fr)	2007-10-26	Procede de preparation de la gemcitabine et de composes intermediaires associes
BE903673Q (fr)	1986-05-20	Nucleosides de types 1,2,4-triazole, leur preparation et leur utilisation
CA1127637A (en)	1982-07-13	5-FLUORO-(.beta.-URIDINE OR 2'-DEOXY-.beta.-URIDINE) DERIVATIVES, A PROCESS FOR PRODUCING THE SAME AND A CARCINOSTATIC AGENT CONTAINING THE SAME
EP0601520A1 (en)	1994-06-15	Trifluorothymidine derivatives, process for producing the same and anti-cancer agent containing the same
KR20080094890A (ko)	2008-10-27	젬시타빈 및 관련 중간체의 제조 방법
LU85864A1 (fr)	1985-12-16	Nouveaux derives du bornane,leur preparation et compositions therapeutiques en contenant
CA2070960A1 (fr)	1992-12-12	Derives de 1,5-diyne-3-cycloalcene, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
HK1005871B (en)	1999-01-29	Pyrimidine nucleoside derivative